Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.

Kapoor, Mahendra Parkash; Suzuki, Koji; Derek, Timm; Ozeki, Makoto; Okubo, Tsutomu

Kapoor, Mahendra Parkash; Suzuki, Koji; Derek, Timm; Ozeki, Makoto; Okubo, Tsutomu.

Afiliação

Kapoor MP; Taiyo Kagaku Co. Ltd., Nutrition Division, 1-3 Takaramachi, Yokkaichi, Mie, 510-0844, Japan.
Suzuki K; Department of Molecular Pathobiology, Mie University, 2-174 Edobashi, Tsu City, Mie, 514 8507, Japan.
Derek T; Suzuka University of Medical Sciences, Suzuka City, Mie, 510-0221, Japan.
Ozeki M; Taiyo International Inc., Minneapolis, Minnesota, 55416, USA.
Okubo T; Taiyo Kagaku Co. Ltd., Nutrition Division, 1-3 Takaramachi, Yokkaichi, Mie, 510-0844, Japan.

Contemp Clin Trials Commun ; 17: 100499, 2020 Mar.

Article em En | MEDLINE | ID: mdl-31890983

Palavras-chave

Amla (Emblica Officinalis Gaertn); Clinical trial; Hematology; Lipid profile; Vascular functions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Contemp Clin Trials Commun Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google